bpc 157 doses BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC 157: Science-Backed Uses, Benefits,
Description
The FUT2 secretor variant p.Trp154Ter influences serum vitamin B 12 concentration via holo-haptocorrin, but not holo-transcobalamin, and is associated with haptocorrin glycosylationHum Mol Genet2017;26:4975-88

[DOI] [PubMed] [Google Scholar] 2.Lederle FA

Inadequate storage Leaving reconstituted peptides at room temperature degrades them rapidly

INTERVIEWER: Vaccines for young children have followed kind of a convoluted path
